M Marchetti, G Barosi, L N Liberato. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antineoplastic Agents/economicsAntineoplastic Agents/therapeutic useChlorambucil/economicsChlorambucil/therapeutic useCost-Benefit AnalysisDisease-Free SurvivalDrug CostsHumansItalyLeukemia, Lymphocytic, Chronic, B-Cell/drug therapyLeukemia, Lymphocytic, Chronic, B-Cell/economicsValue of LifeVidarabine/analogs & derivativesVidarabine/economicsVidarabine/therapeutic use
Substances： See more » Antineoplastic AgentsChlorambucilVidarabinefludarabine
Year: 2001 PMID： 11302140 DOI： 10.1056/NEJM200104123441511
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245